135 related articles for article (PubMed ID: 16787245)
1. Therapeutic AIDS vaccines.
Bourinbaiar AS; Root-Bernstein RS; Abulafia-Lapid R; Rytik PG; Kanev AN; Jirathitikal V; Orlovsky VG
Curr Pharm Des; 2006; 12(16):2017-30. PubMed ID: 16787245
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with therapeutic AIDS vaccines.
Bourinbaiar AS; Abulafia-Lapid R
Expert Rev Vaccines; 2005 Jun; 4(3):289-304. PubMed ID: 16026245
[TBL] [Abstract][Full Text] [Related]
3. Autoimmunity, alloimmunization and immunotherapy of AIDS.
Bourinbaiar AS; Abulafia-Lapid R
Autoimmun Rev; 2005 Jul; 4(6):403-9. PubMed ID: 16081032
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Reservoir Dynamics after Vaccination and Antiretroviral Therapy Interruption Are Associated with Dendritic Cell Vaccine-Induced T Cell Responses.
Andrés C; Plana M; Guardo AC; Alvarez-Fernández C; Climent N; Gallart T; León A; Clotet B; Autran B; Chomont N; Gatell JM; Sánchez-Palomino S; García F
J Virol; 2015 Sep; 89(18):9189-99. PubMed ID: 26109727
[TBL] [Abstract][Full Text] [Related]
5. Approaches to preventative and therapeutic HIV vaccines.
Gray GE; Laher F; Lazarus E; Ensoli B; Corey L
Curr Opin Virol; 2016 Apr; 17():104-109. PubMed ID: 26985884
[TBL] [Abstract][Full Text] [Related]
6. HIV vaccines in infants and children.
Lambert JS
Paediatr Drugs; 2005; 7(5):267-76. PubMed ID: 16220994
[TBL] [Abstract][Full Text] [Related]
7. Towards the development of a therapeutic vaccine for the treatment of HIV-1 infection: are we closer than ever?
Egan MA
Expert Rev Vaccines; 2007 Jun; 6(3):289-91. PubMed ID: 17542741
[No Abstract] [Full Text] [Related]
8. Understanding HIV infection for the design of a therapeutic vaccine. Part II: Vaccination strategies for HIV.
de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
Ann Pharm Fr; 2015 May; 73(3):169-79. PubMed ID: 25528627
[TBL] [Abstract][Full Text] [Related]
9. Cytokine-adjuvanted HIV-DNA vaccination strategies.
Lori F; Weiner DB; Calarota SA; Kelly LM; Lisziewicz J
Springer Semin Immunopathol; 2006 Nov; 28(3):231-8. PubMed ID: 17053912
[TBL] [Abstract][Full Text] [Related]
10. Effect of therapeutic intensification followed by HIV DNA prime and rAd5 boost vaccination on HIV-specific immunity and HIV reservoir (EraMune 02): a multicentre randomised clinical trial.
Achenbach CJ; Assoumou L; Deeks SG; Wilkin TJ; Berzins B; Casazza JP; Lambert-Niclot S; Koup RA; Costagliola D; Calvez V; Katlama C; Autran B; Murphy RL;
Lancet HIV; 2015 Mar; 2(3):e82-91. PubMed ID: 26424549
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.
Dorrell L; Yang H; Iversen AK; Conlon C; Suttill A; Lancaster M; Dong T; Cebere I; Edwards A; Rowland-Jones S; Hanke T; McMichael AJ
AIDS; 2005 Aug; 19(12):1321-3. PubMed ID: 16052088
[TBL] [Abstract][Full Text] [Related]
12. Understanding HIV infection for the design of a therapeutic vaccine. Part I: Epidemiology and pathogenesis of HIV infection.
de Goede AL; Vulto AG; Osterhaus AD; Gruters RA
Ann Pharm Fr; 2015 Mar; 73(2):87-99. PubMed ID: 25496723
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo production of autologous whole inactivated HIV-1 for clinical use in therapeutic vaccines.
Gil C; Climent N; García F; Hurtado C; Nieto-Márquez S; León A; García MT; Rovira C; Miralles L; Dalmau J; Pumarola T; Almela M; Martinez-Picado J; Lifson JD; Zamora L; Miró JM; Brander C; Clotet B; Gallart T; Gatell JM
Vaccine; 2011 Aug; 29(34):5711-24. PubMed ID: 21679735
[TBL] [Abstract][Full Text] [Related]
14. Ongoing trials of immune-based therapies for HIV infection in adults.
Ross RW; Wright ME; Tavel JA
Expert Opin Biol Ther; 2001 May; 1(3):413-24. PubMed ID: 11727515
[TBL] [Abstract][Full Text] [Related]
15. DC immunotherapy in HIV-1 infection induces a major blood transcriptome shift.
de Goede AL; Andeweg AC; van den Ham HJ; Bijl MA; Zaaraoui-Boutahar F; van IJcken WF; Wilgenhof S; Aerts JL; Gruters RA; Osterhaus AD;
Vaccine; 2015 Jun; 33(25):2922-9. PubMed ID: 25913415
[TBL] [Abstract][Full Text] [Related]
16. Updated Studies on the Development of HIV Therapeutic Vaccine.
Larijani MS; Ramezani A; Sadat SM
Curr HIV Res; 2019; 17(2):75-84. PubMed ID: 31210114
[TBL] [Abstract][Full Text] [Related]
17. Dendritic Cell-Based Immunotherapies to Fight HIV: How Far from a Success Story? A Systematic Review and Meta-Analysis.
Coelho AV; de Moura RR; Kamada AJ; da Silva RC; Guimarães RL; Brandão LA; de Alencar LC; Crovella S
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27898045
[TBL] [Abstract][Full Text] [Related]
18. Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial.
Ugen KE; Boyer JD; Wang B; Bagarazzi M; Javadian A; Frost P; Merva MM; Agadjanyan MG; Nyland S; Williams WV; Coney L; Ciccarelli R; Weiner DB
Vaccine; 1997 Jun; 15(8):927-30. PubMed ID: 9234550
[TBL] [Abstract][Full Text] [Related]
19. The basis for HIV immunotherapeutic vaccines.
Peters BS
Vaccine; 2001 Dec; 20(5-6):688-705. PubMed ID: 11738732
[TBL] [Abstract][Full Text] [Related]
20. Gene combination raises broad human immunodeficiency virus-specific cytotoxicity.
Calarota SA; Kjerrström A; Islam KB; Wahren B
Hum Gene Ther; 2001 Sep; 12(13):1623-37. PubMed ID: 11535166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
